Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections:: A prospective study

被引:97
作者
Sotto, A
De Boever, CM
Fabbro-Peray, P
Gouby, A
Sirot, D
Jourdan, J
机构
[1] Univ Nimes, Hop Caremeau, Serv Med Interne B, Lab Therapeut, F-30029 Nimes, France
[2] Hop Gaston Doumergue, Dept Med Informat, F-30029 Nimes, France
[3] Hop Gaston Doumergue, Microbiol Lab, F-30029 Nimes, France
[4] Fac Med Clermont Ferrand, Bacteriol Lab, F-63001 Clermont Ferrand, France
关键词
D O I
10.1128/JCM.39.2.438-444.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
From November 1998 to February 1999 we prospectively evaluated the prevalence of resistance to penicillins, cephalosporins, carbapenem, quinolones, aminoglycosides, and trimethoprim-sulfamethoxazole (SXT) in 320 Escherichia coli isolates isolated from hospitalized patients with acute urinary tract infections (UTIs). We also studied for these strains risk factors for resistance to amoxicillin-clavulanic acid (AMC), fluoroquinolones (FQs), and SXT. Resistance rates were consistent with those from major recent studies reported in the literature. Multivariate analyses selected the following factors as being significantly associated with E. coli resistance: (i) for resistance to AMC, prior (1 year) UTI (odds ratio [OR] = 2.71, P = 0.006), prior (1 year) urinary catheter (OR = 2.98, P = 0.0025), and prior (6 months) antibiotic exposure (OR = 2.68, P = 0.005); (ii) for resistance to FQs male sex (OR = 3.87, P = 0.03), with a trend toward significance for age >65 years (OR = 7.67, P = 0.06) and prior (1 year) UTI (OR = 2.98, P = 0.07); and (iii) for resistance to SXT, male sex (OR = 1.91, P = 0.046), hospitalization in an intermediate-term care unit (OR = 2.18, P = 0.008), and prior (1 year) UTI (OR = 2.03, P = 0.03). Ours results suggest that prior UTI is a common risk factor for resistance to the different antibiotics tested. Although few studies on risk factors for E. coli resistance to antibiotics have been published, careful interpretation of their findings, taking into consideration the population, infection site, and period studied, should contribute to the formulation of a better strategy that can be used to overcome antibiotic resistance.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 40 条
[1]  
Allen UD, 1999, CAN MED ASSOC J, V160, P1436
[2]   HOSPITAL SURVEILLANCE OF THE SUSCEPTIBILITY OF ESCHERICHIA-COLI AND KLEBSIELLA TO CO-AMOXYCLAV IN 1994 [J].
ALLOUCH, PY ;
LABIA, R ;
PINA, P ;
MORIN, E .
MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (8-9) :934-939
[3]   Antibiotic resistance in Spain: What can be done? [J].
Baquero, F ;
Baraibar, R ;
Campos, J ;
Dominguez, L ;
Garau, J ;
GarciaRodriguez, JA ;
Guerra, L ;
Palau, E ;
PerezGorricho, B ;
PerezTrallero, E ;
Prats, G ;
ReyDuran, R ;
Bremon, AR .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :819-823
[4]   DEVELOPMENT OF ANTIBACTERIAL RESISTANCE - THE DUTCH EXPERIENCE [J].
BEUNDERS, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 :17-22
[5]   Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain [J].
Blanco, JE ;
Blanco, M ;
Mora, A ;
Blanco, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (08) :2184-2185
[6]   Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center [J].
Canawati, HN ;
ElFarra, R ;
Seymour, J ;
Shimashita, J ;
Dunn, D ;
Montgomerie, JZ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :133-138
[7]   Inhibitor-resistant TEM β-lactamases:: phenotypic, genetic and biochemical characteristics [J].
Chaïbi, EB ;
Sirot, D ;
Paul, G ;
Labia, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :447-458
[8]  
De Mouy D, 1999, PRESSE MED, V28, P1624
[9]   ANTIMICROBIAL SUSCEPTIBILITY OF ESCHERICHIA-COLI FROM BLOOD AND URINE CULTURES IN 15 GENERAL HOSPITALS IN THE SOUTH-WEST OF FRANCE [J].
DELARBRE, JM ;
GRASMICK, CP ;
COUMENGES, P ;
DANJEAN, MP ;
DUBOURDIEUARLABOSSE, B ;
COURREGE, A ;
HECHE, X ;
LABONNE, F ;
LAFARGUE, JP ;
LARROUY, P ;
MELON, M ;
JEAN, DP ;
ROUGIER, C ;
SANCHEZ, R .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :535-538
[10]   ESCHERICHIA-COLI AT A GENERAL-HOSPITAL BETWEEN 1982 AND 1993 [J].
DUBLANCHET, A ;
BURNAT, C .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :530-534